Adaptive COVID-19 Treatment Trial (ACTT)
Clinical trial NCT04280705 · COMPLETED
Trial details
- NCT number
- NCT04280705
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-21
- Primary completion
- 2020-05-21
- Enrollment
- 1062
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.